{
    "Trade/Device Name(s)": [
        "FastPack High Sensitivity C-Reactive Protein Immunoassay",
        "FastPack High Sensitivity C-Reactive Protein Calibrator Kit",
        "FastPack High Sensitivity C-Reactive Protein Controls",
        "FastPack High Sensitivity C-Reactive Protein Method Verification Kit"
    ],
    "Submitter Information": "Qualigen, Inc.",
    "510(k) Number": "K141689",
    "Predicate Device Reference 510(k) Number(s)": [
        "K051564",
        "K050537",
        "K041799"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DCK",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "December 15, 2014",
    "Summary Letter Received Date": "December 18, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5270",
        "21 CFR 862.1150",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "C-reactive protein immunological test system",
        "Calibrator",
        "Quality control material (Assayed and Unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "C-reactive protein (CRP)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "FastPack Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay",
        "Paramagnetic particle immunoassay",
        "Sandwich immunoassay"
    ],
    "Methodologies": [
        "Immunological quantitation"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Verification kit"
    ],
    "Document Summary": "FDA 510(k) summary for the Qualigen FastPack High Sensitivity C-Reactive Protein Immunoassay and associated calibrator, control, and verification kits for quantification of CRP using a chemiluminescent immunoassay on the FastPack Analyzer.",
    "Indications for Use Summary": "For evaluation of conditions associated with inflammation in otherwise healthy individuals; intended for use with the FastPack Analyzer, including calibrating, quality control, and verification of the quantitative CRP immunoassay; not for point-of-care use.",
    "fda_folder": "Immunology"
}